OpenAlex
PricingAboutJobs
Log inGet started
Work

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis?the TOPIC study: a randomised controlled trial

HTML

Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(05)70798-4
Authors: Alan Smyth, Kelvin H-V Tan, Pauline Hyman-Taylor, Michael Mulheran, Sarah Lewis, David Stableforth, Alan Knox
Institutions: University of Nottingham, Nottingham City Hospital, University of Leicester, Medical Research Council, Heartlands Hospital
Language: English

Topic: Cystic Fibrosis Research Advances
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cystic fibrosis, pulmonary exacerbations, dosing regimen, once-daily dosing, three-times-daily dosing, Pseudomonas aeruginosa, ceftazidime, FEV1, nephrotoxicity, serum creatinine, children, adults, hearing loss, acute dizziness, intravenous antibiotics
SDG: Good health and well-being

Open Access status: closed

Funder: Cystic Fibrosis Trust
OpenAlex ID: W1975806439
FWCI: 12.99
Cites: 22
Cited by: 237
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security